Tag: AI

Automating molecule design will help to optimize drug development process

drug development
Researchers from MIT’s Computer Science and Artificial Intelligence Laboratory and Department of Electrical Engineering and Computer Science developed a model that selects lead molecule candidates based on desired properties.

Association of medical AI systems developers and users was established in Russia

The Association was established with the support of Russian Venture Company (RVC) to accelerate the introduction of advanced artificial intelligence technology in the clinical practice.

BASF will develop new catalyst technologies with Citrine Informatics

BASF and Citrine Informatics are collaborating to use artificial intelligence (AI) to accelerate the development of new environmental catalyst technologies.

Deloitte’s recent survey reflects the increasing role of real-world evidence

Deloitte’s real-world evidence (RWE) benchmarking survey studies how biopharma companies are using RWE, what they are investing in, areas of impact, and the hurdles to successful adoption.

Adents and Microsoft developed a new blockchain serialization solution

Adents in collaboration with Microsoft has developed a new unit-level product track & trace platform utilizing Blockchain and AI technologies. Adents NovaTrack offers end-to-end traceability.

GSK started a drug development partnership with Cloud Pharmaceuticals

drug discovery
Cloud Pharmaceuticals, an Artificial Intelligence-driven drug design and development company, entered into drug discovery collaboration with GlaxoSmithKline (GSK).

New digital platform is expected to revolutionize drug discovery

The launch date of the new iPlexus will be on June 30, 2018. The platform is expected to transform the exchange of research work not only in preclinical life research but also in drug discovery.

ICON will use Intel Pharma Analytics Platform in clinical trials

clinical trials
ICON, a global provider of drug development solutions, agreed on preliminary deal terms with Intel Corporation to enable ICON to offer the Intel Pharma Analytics Platform for use in clinical trials.

BenevolentAI received financing to push forward AI enabled drug development

The company will use the funds to significantly scale its drug development activities, broaden the disease areas on which it focuses, and extend its AI platform capabilities even further.

Atomwise startup aims to become the key AI partner for pharma and biotech

Artificial Intelligence
Atomwise Inc., the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC, and B Capital Group.

Microsoft and Apollo Hospitals join forces to develop AI network for healthcare

Tech giant Microsoft and leading Indian speciality hospital, Apollo Hospitals, will work to develop and deploy new machine learning models to predict patient risk for heart disease and assist doctors on treatment plans.

South Korea will support AI drug development

drug discovery
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes

BenevolentAI acquired a new R&D facility on the Babraham Research Campus

drug discovery
BenevolentAI, one of the world’s largest private AI companies, acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge (UK) for an undisclosed sum.

UK blockchain startup teams up with Mongolian government to stop fake medicines

fake drugs
FarmaTrust, a UK blockchain startup, has officially signed a partnership with the Mongolian government to pilot a one-year project aimed at preventing the creation and distribution of counterfeit medications.

Drug discovery IT solutions will reach $5.3 billion globally by 2020

The latest analysis by Frost & Sullivan highlights the growing interest in big data analytics and artificial intelligence-based solutions

WuXi NextCODE and Rhythm Pharmaceuticals started a partnership

WuXi NextCODE, the emerging global standard platform for genomic data, announced a partnership with Rhythm Pharmaceuticals